Publication:
Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma.

No Thumbnail Available

Date

2019-10-02

Authors

Boada, Aram
Tejera-Vaquerizo, Antonio
Ribero, Simone
Puig, Susana
Moreno-Ramírez, David
Quaglino, Pietro
Osella-Abate, Simona
Cassoni, Paola
Malvehy, Josep
Carrera, Cristina

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Sentinel lymph node (SLN) biopsy is useful for the prognostic stratification of patients with thick melanoma. Identifying which variables are associated with SLN involvement and establishing risk in different subgroups of patients could be useful for guiding the indication of SLN biopsy. The value of complete lymph node dissection (CLND) in patients with a positive SLN biopsy is currently under debate. To identify factors associated with SLN involvement in thick melanoma we performed a multicentric retrospective cohort study involving 660 patients with thick melanoma who had undergone SLN biopsy. To analyze the role of CLND in thick melanoma patients with a positive SLN biopsy, we built a multivariate Cox proportional hazards model for melanoma-specific survival (MSS) and disease-free survival (DFS) and compared 217 patients who had undergone CLND with 44 who had not. The logistic regression analysis showed that age, histologic subtype, ulceration, microscopic satellitosis, and lymphovascular invasion were associated with nodal disease. The CHAID (Chi-squared Automatic Interaction Detection) decision tree showed ulceration to be the most important predictor of lymphatic involvement. For nonulcerated melanomas, the histologic subtype lentigo maligna melanoma was associated with a low rate of SLN involvement (4.3%). No significant differences were observed for DFS and MSS between the CLND performed and not-performed groups. Nodal status on CLND was associated with differences in DFS and MSS rates. We identified subgroups of thick melanoma patients with a low likelihood of SLN involvement. CLND does not offer survival benefit, but provides prognostic information.

Description

MeSH Terms

Aged
Female
Humans
Logistic Models
Lymph Node Excision
Lymphatic Metastasis
Male
Melanoma
Middle Aged
Prognosis
Retrospective Studies
Sentinel Lymph Node
Sentinel Lymph Node Biopsy

DeCS Terms

CIE Terms

Keywords

Complete lymph node dissection, Melanoma, Prognosis, Sentinel lymph node biopsy

Citation